These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 15372180)

  • 1. [Therapy-related hematologic neoplasias after breast cancer. Epidemiologic, etiologic and cytogenetic aspects and new risk factors according to published data and own results].
    Haase D; Hanf V; Schulz T
    Med Klin (Munich); 2004 Sep; 99(9):506-17. PubMed ID: 15372180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence of secondary leukemias.
    Leone G; Mele L; Pulsoni A; Equitani F; Pagano L
    Haematologica; 1999 Oct; 84(10):937-45. PubMed ID: 10509043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and susceptibility to therapy-related myeloid neoplasms.
    Leone G; Fianchi L; Pagano L; Voso MT
    Chem Biol Interact; 2010 Mar; 184(1-2):39-45. PubMed ID: 20026017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of therapy-related leukemia and myelodysplastic syndrome.
    Kantarjian HM; Estey EH; Keating MJ
    Hematol Oncol Clin North Am; 1993 Feb; 7(1):81-107. PubMed ID: 7680643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.
    Kröger N; Damon L; Zander AR; Wandt H; Derigs G; Ferrante P; Demirer T; Rosti G; ; ;
    Bone Marrow Transplant; 2003 Dec; 32(12):1153-7. PubMed ID: 14647269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary myelodysplastic syndrome/acute myeloid leukaemia following mitoxantrone-based therapy for breast carcinoma.
    Saso R; Kulkarni S; Mitchell P; Treleaven J; Swansbury GJ; Mehta J; Powles R; Ashley S; Kuan A; Powles T
    Br J Cancer; 2000 Jul; 83(1):91-4. PubMed ID: 10883674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer.
    Le Deley MC; Suzan F; Cutuli B; Delaloge S; Shamsaldin A; Linassier C; Clisant S; de Vathaire F; Fenaux P; Hill C
    J Clin Oncol; 2007 Jan; 25(3):292-300. PubMed ID: 17159192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moderate increase of secondary hematologic malignancies after myeloablative radiochemotherapy and autologous stem-cell transplantation in patients with indolent lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group.
    Lenz G; Dreyling M; Schiegnitz E; Haferlach T; Hasford J; Unterhalt M; Hiddemann W
    J Clin Oncol; 2004 Dec; 22(24):4926-33. PubMed ID: 15611507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
    Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
    J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case-control study on the therapy of childhood cancer and the occurrence of second malignant neoplasms in Germany.
    Kaatsch P; Reinisch I; Spix C; Berthold F; Janka-Schaub G; Mergenthaler A; Michaelis J; Blettner M
    Cancer Causes Control; 2009 Aug; 20(6):965-80. PubMed ID: 19263232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy-related myelodysplastic syndrome after autologous stem cell transplantation for breast cancer.
    Nichols G; de Castro K; Wei LX; Griffin M; Lin N; Oratzi A; Murty VV; Troxel A; Vahdat L; Hesdorffer C
    Leukemia; 2002 Sep; 16(9):1673-9. PubMed ID: 12200680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Leukemia in patients with breast carcinoma after adjuvant chemotherapy and/or postoperative radiotherapy].
    Sack H
    Strahlenther Onkol; 1995 Jul; 171(7):420-1. PubMed ID: 7631268
    [No Abstract]   [Full Text] [Related]  

  • 14. Secondary acute myelogenous leukemia and myelodysplasia without abnormalities of chromosome 11q23 following treatment of acute leukemia with topoisomerase II-based chemotherapy.
    Seiter K; Feldman EJ; Sreekantaiah C; Pozzuoli M; Weisberger J; Liu D; Papageorgio C; Weiss M; Kancherla R; Ahmed T
    Leukemia; 2001 Jun; 15(6):963-70. PubMed ID: 11417484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
    Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
    Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy-induced leukemia -- an underestimated complication of antineoplastic chemotherapy?].
    Dührsen U
    Zentralbl Gynakol; 2005 Aug; 127(4):235-41. PubMed ID: 16037905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased risk for therapy-associated hematologic malignancies in patients with carcinoma of the breast and combined homozygous gene deletions of glutathione transferases M1 and T1.
    Haase D; Binder C; Bünger J; Fonatsch C; Streubel B; Schnittger S; Griesinger F; Westphal G; Schoch C; Knopp A; Berkovicz D; Krieger O; Wörmann B; Hilgers R; Hallier E; Schulz T
    Leuk Res; 2002 Mar; 26(3):249-54. PubMed ID: 11792413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of leukemia after chemotherapy and radiation treatment for breast cancer.
    Curtis RE; Boice JD; Stovall M; Bernstein L; Greenberg RS; Flannery JT; Schwartz AG; Weyer P; Moloney WC; Hoover RN
    N Engl J Med; 1992 Jun; 326(26):1745-51. PubMed ID: 1594016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series.
    Pedersen-Bjergaard J; Philip P; Larsen SO; Andersson M; Daugaard G; Ersbøll J; Hansen SW; Hou-Jensen K; Nielsen D; Sigsgaard TC
    Leukemia; 1993 Dec; 7(12):1975-86. PubMed ID: 8255096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary myelodysplastic syndromes and leukaemias.
    Levine EG; Bloomfield CD
    Clin Haematol; 1986 Nov; 15(4):1037-80. PubMed ID: 3552347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.